Rosuvastatin should be used with caution in patients with liver impairment and is not recommended for those with active liver disease. Dosage adjustments or alternative treatments may be necessary.

In patients with kidney impairment, lower initial doses of rosuvastatin are advised. Typically, the starting dose is reduced, and renal function is closely monitored to avoid toxicity.